 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/17/2024 |
$69.58 |
$69.90 |
$67.86 |
$67.93 |
1.29M | | 04/18/2024 |
$67.50 |
$68.53 |
$66.84 |
$67.00 |
1.03M | | 04/19/2024 |
$66.88 |
$67.80 |
$64.82 |
$67.55 |
1.61M | | 04/22/2024 |
$67.90 |
$67.90 |
$65.64 |
$66.29 |
1.18M | | 04/23/2024 |
$66.72 |
$68.76 |
$65.53 |
$65.57 |
1.28M |
|
|
| Cytokinetics is a biopharmaceutical company focused on discovering, developing and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. Co.'s clinical-stage drug candidates are: Omecamtiv mecarbil, which is being evaluated for the potential treatment of heart failure; Reldesemtiv, which is being evaluated for treatment in patients with amyotrophic lateral sclerosis; Aficamten, which is an oral, small molecule cardiac myosin inhibitor being evaluated in patients with symptomatic, obstructive hypertrophic cardiomyopathy; and CK-3772271, its second cardiac myosin inhibitor. | |
|
Cytokinetics (CYTK) has the following price history information. Looking back at CYTK historical stock prices for the last five trading days, on April 17, 2024, CYTK opened at $69.58, traded as high as $69.90 and as low as $67.86, and closed at $67.93. Trading volume was a total of 1.29M shares. On April 18, 2024, CYTK opened at $67.50, traded as high as $68.53 and as low as $66.84, and closed at $67.00. Trading volume was a total of 1.03M shares. On April 19, 2024, CYTK opened at $66.88, traded as high as $67.80 and as low as $64.82, and closed at $67.55. Trading volume was a total of 1.61M shares. On April 22, 2024, CYTK opened at $67.90, traded as high as $67.90 and as low as $65.64, and closed at $66.29. Trading volume was a total of 1.18M shares. On April 23, 2024, CYTK opened at $66.72, traded as high as $68.76 and as low as $65.53, and closed at $65.57. Trading volume was a total of 1.28M shares.
CYTK Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cytokinetics shares, starting with a $10,000 purchase of CYTK, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/25/2014 |
|
| End date: |
04/23/2024 |
|
| Start price/share: |
$4.59 |
|
| End price/share: |
$65.57 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
1,328.54% |
|
| Average Annual Total Return: |
30.45% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$142,809.51 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/17/2024 | $67.93 | | 04/18/2024 | $67.00 | | 04/19/2024 | $67.55 | | 04/22/2024 | $66.29 | | 04/23/2024 | $65.57 |
|
|
Free CYTK Email Alerts:
